Physician profile
Kyle D Martin
NPI 1760004071
$19,039.19
in general payments reported to CMS, 2019-2025
11 companies · $5,921 in 2025
The $5,921 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,783 · 2022: $478 · 2023: $2,333 · 2024: $8,524 · 2025: $5,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,834 · Travel and Lodging: $3,794 · Consulting Fee: $3,400 · Food and Beverage: $2,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,834.32 |
| Travel and Lodging | $3,793.66 |
| Consulting Fee | $3,400.00 |
| Food and Beverage | $2,749.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $6,317.45 | 2022-2025 | Air Optix, Dailies Total1, Total30 |
| Coopervision INC. | $5,314.93 | 2023-2025 | Clariti Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $4,252.47 | 2022-2025 | Acuvue |
| Valley Contax, INC. | $1,651.03 | 2021 | |
| Bausch & Lomb Americas INC. | $625.86 | 2022-2025 | Infuse, Biotrue One Day |
| Biotissue Holdings INC. | $242.18 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $228.60 | 2024-2025 | Xdemvy |
| Visionary Optics LLC | $149.28 | 2023 | |
| Oyster Point Pharma, INC. | $125.00 | 2024 | Tyrvaya |
| Allergan, INC. | $119.11 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.